Chapter 241 Sudden Circumstances at the Containment Facility
Meanwhile, at an undisclosed location, somewhere in Japan. Su Xue was walking towards Lin Feng who was glancing at the newest mutations he had put in his army. They are composed of 10 men and 20 women, each one with the power to fair against Goliath or Juggernaut.
"Master…we may have a problem, it's Crimson. We have lost contact with her," Su Xue reported.
"I already know," Lin Feng replied nonchalantly. "The enemy has taken her, she failed her mission."
"Look's what that arrogant woman got herself into," Violet harrumphed. "She may be one of the strongest but she is careless and doesn't respect her enemies."
When Violet said that, she received an intimidating glare from Lin Feng.
"That's how the strong think. They are humans, manning a machine. Remove those machines and they are just feeble human beings. She has the right to be arrogant, but I don't accept failure so…"
Violet stood in place, shaking inwardly with fear. There he goes again, being so scary.
"Are you suggesting that we end her off? Aren't you going to be lenient towards her like you did to Violet and Seo-Jun?" Su Xue asked, seeking clarification.
Lin Feng glanced at Su Xue and then to the two he rescued from the Philippines, and to the newest recruits.
"Crimson's pill has been surgically removed by the Blackwatch, therefore I have no control over her and thus she posed as an enemy, similar to what happened to Andrea. However, it doesn't mean I don't learn from my mistakes. I have made an upgrade to my pawns, and that is—" Lin Feng paused as he opened his system, and then, with a single tap of the icon, an effect followed.
"We shall wait—"
***
On the same day, in the Philippines New Clark Containment Facility. Crimson's skin was pierced with numerous pins and tubes, as she lay surrounded by medical equipment. This setup was part of an intensive experiment conducted by the Blackwatch scientists. They were monitoring every physiological aspect of her body, treating her more like a subject in a lab experiment than a human. This situation starkly contrasts with her previous role and status, highlighting the extreme measures taken by Blackwatch in their research endeavors.
"Please…let…me go," Crimson sobbed. "It wasn't me…I swear."
But her pleas fell on deaf ears as the Blackwatch scientist continued to proceed with their procedures.
One of the scientists, a young man in his early twenties approached the chief scientist, Doctor Aaron.
"Sir…I think we are being too harsh on her. We have removed the pill and so she is returned to her former self. She is confused and is not aware of our past encounter with her."
"What are you implying?" Doctor Aaron asked.
"She is not our enemy anymore, we can turn her into our ally and then use her against the progenitor. Her magical abilities are too powerful to waste," the young scientist suggested, his tone hinting at both concern and strategic thinking.
"The commander-in-chief has explicitly stated that we are to conduct experiments to understand her kind more so we can develop a countermeasure. Sure she is innocent but the information she holds in her genes is invaluable. Maybe we'll start considering the idea once we are fini—hmm? What's happening?"
The monitors beeped in alarm as Crimson's vital signs began to fluctuate rapidly.?She started bleeding from her eyes, nose, ears, and mouth, indicating a severe case of hemorrhagic diathesis, possibly triggered by the experimental procedures or an underlying pathological reaction.
Doctor Aaron immediately switched to a clinical mode. "We have a case of spontaneous multi-site hemorrhage. Initiate protocol for disseminated intravascular coagulation (DIC) management, now!" he ordered firmly and authoritatively.
"Administer 10 units of fresh frozen plasma and platelet concentrate, stat!" he continued. "Prepare for a possible transfusion. We need to stabilize her coagulopathy."
As the team sprang into action, Doctor Aaron quickly assessed Crimson's condition. "Check her prothrombin time and activated partial thromboplastin time. I need those values immediately," he said, referring to tests that measure blood clotting.
One of the team members reported, "Her PT and aPTT are significantly prolonged, Doctor."
Acknowledging the severity of the situation, Doctor Aaron gave further orders. "Start an infusion of Vitamin K and consider administering recombinant factor VIIa if the bleeding doesn't stop. We need to counteract this coagulation failure."
Another scientist prepared an IV line to administer the ordered treatments. Doctor Aaron, while monitoring Crimson's vitals, said, "Keep an eye on her hemodynamic status. If there's any sign of hypovolemic shock, we'll need to respond quickly."
As the medical team in the New Clark Containment Facility worked diligently under Doctor Aaron's guidance, the situation with Crimson took a turn for the worse. The monitors hooked up to her, which included a multiparameter patient monitor displaying vital signs like heart rate, blood pressure, and oxygen saturation, started showing alarming signs of multiple organ failures.
"Her renal function is declining rapidly, and liver enzymes are elevated!" one of the scientists announced, reading the data from the biochemical analyzers connected to Crimson.
Doctor Aaron's expression grew more serious. "We're dealing with acute renal failure and hepatic dysfunction. Start her on continuous renal replacement therapy (CRRT) immediately to manage the renal failure," he ordered. CRRT is a form of dialysis used to support kidney function in critically ill patients.
"Also, administer N-acetylcysteine for hepatic protection. Check her ammonia levels and lactate dehydrogenase (LDH)," he added, specifying treatments and tests for liver function.
As the team hurried to follow his orders, another monitor displayed a critical decrease in Crimson's cardiac output. "Her heart is struggling. Start an inotrope support. Prepare dobutamine infusion," Doctor Aaron commanded, referring to a medication used to improve heart function and blood flow.
Simultaneously, he turned to a respiratory therapist. "Her oxygen saturation is dropping. Let's intubate her and start mechanical ventilation to ensure adequate oxygenation," he instructed, indicating the need for advanced respiratory support due to failing lung function.
The situation was a dire illustration of the body's interconnected systems collapsing under extreme stress.
"I don't understand, what's causing this?" The young scientist asked.
"I don't know either…it seems like she is self-destructing…" Aaron clicked his tongue in frustration. "Increase the dose of sedatives. We need to minimize her physiological stress response. It could be exacerbating her condition."
The young scientist nodded and quickly adjusted the medication, hoping to stabilize Crimson's deteriorating condition. "I'm increasing the sedative dosage now," he reported, administering the drugs through the IV line.
Doctor Aaron closely watched the monitors, his mind racing through possible causes and solutions. "Run a full panel of toxicology tests. Check for any unknown compounds in her system. We need to rule out any external toxins or self-produced biochemical agents that might be causing this reaction."
One of the other team members, a toxicologist, began preparing the necessary tests. "I'm on it, Doctor," she said, swiftly collecting blood samples for analysis.
Doctor Aaron then turned his attention back to the rest of the team. "Monitor her brain activity. We can't rule out neurological causes. Prepare for an EEG," he instructed, referring to an electroencephalogram, a test used to evaluate the electrical activity in the brain.
"Sir we are losing her."
Suddenly, the tone in the room shifted to one of high alert as the multiparameter patient monitor emitted a continuous, high-pitched tone - a clear indication that Crimson was flatlining.
"Cardiac arrest! Begin CPR, now!" Doctor Aaron shouted, his calm demeanor giving way to urgent command. "Prepare for defibrillation. Charge to 200 joules."
A team member immediately started chest compressions, rhythmically pressing down on Crimson's chest to manually pump blood through her body. Another scientist quickly wheeled in a defibrillator.
"Everyone clear!" Doctor Aaron called out as he placed the defibrillation paddles on Crimson's chest. The room fell silent for a moment, except for the hum of the defibrillator as it charged. With a firm press, he delivered the shock.
Crimson's body jerked slightly from the force of the defibrillation. The team members anxiously watched the monitors, hoping for a sign of a heartbeat.
"Continue compressions. Administer 1 mg of epinephrine," Doctor Aaron instructed, his voice steady despite the critical situation. Epinephrine, also known as adrenaline, is used during cardiac arrest to increase the likelihood of restoring a heartbeat.
As the team member resumed chest compressions, another injected the epinephrine into Crimson's IV line. Doctor Aaron kept a vigilant eye on the monitor, looking for any change in her cardiac rhythm.
But despite their best efforts, the monitor showed no response. Crimson's heart did not restart. After several more attempts at resuscitation, including additional rounds of defibrillation and administration of life-saving drugs, it became clear that their efforts were in vain. The flatline on the monitor continued, unchanging.
Doctor Aaron, with a heavy heart, finally gave the order to cease resuscitation efforts. "Stop compressions," he said quietly.
He looked at the clock and noted the time.
Doctor Aaron removed his gloves and stepped back, taking a moment to compose himself. He then turned to his team.
"We need to conduct a full autopsy. Document everything," he instructed. "We have to find out what happened to her. The Commander-in-Chief would definitely want an explanation about this."
The sourc𝗲 of this content is free(w)ebnov(𝒆)l